| # | Title | Journal | Year | Citations |
|---|
| 1 | 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension | Clinical and Experimental Hypertension | 1999 | 471 |
| 2 | Elevated Heart Rate: A Major Risk Factor for Cardiovascular Disease | Clinical and Experimental Hypertension | 2004 | 248 |
| 3 | The Blood Pressure-Lowering Effect and Safety of Chlorogenic Acid from Green Coffee Bean Extract in Essential Hypertension | Clinical and Experimental Hypertension | 2006 | 206 |
| 4 | The Effects of Blood Pressure Reduction in Older Patients: An Overview of Five Randomized Controlled Trials in Elderly Hypertensives | Clinical and Experimental Hypertension | 1993 | 165 |
| 5 | Oxidative Stress in Hypertension | Clinical and Experimental Hypertension | 2004 | 164 |
| 6 | Neutrophil to lymphocyte and platelet to lymphocyte ratio in patients with dipper versus non-dipper hypertension | Clinical and Experimental Hypertension | 2014 | 152 |
| 7 | Dysregulation of Hepatic Superoxide Dismutase, Catalase and Glutathione Peroxidase in Diabetes: Response to Insulin and Antioxidant Therapies | Clinical and Experimental Hypertension | 2004 | 149 |
| 8 | The Consequences of Traumatic Brain Injury on Cerebral Blood Flow and Autoregulation: A Review | Clinical and Experimental Hypertension | 1999 | 134 |
| 9 | SYMPATHETIC NERVOUS SYSTEM, DIABETES, AND HYPERTENSION | Clinical and Experimental Hypertension | 2001 | 134 |
| 10 | World Health Organisation–International Society of Hypertension (WHO/ISH) Hypertension Guidelines | Clinical and Experimental Hypertension | 2004 | 134 |
| 11 | The Effect of Cognitive Behavior Therapy-Based “Forest Therapy” Program on Blood Pressure, Salivary Cortisol Level, and Quality of Life in Elderly Hypertensive Patients | Clinical and Experimental Hypertension | 2012 | 132 |
| 12 | Effect of Dietary Fiber and Protein Intake on Blood Pressure: A Review of Epidemiologic Evidence | Clinical and Experimental Hypertension | 1999 | 128 |
| 13 | Arterial Stiffness: Pathophysiology and Clinical Impact | Clinical and Experimental Hypertension | 2004 | 127 |
| 14 | Risers and Extreme‐Dippers of Nocturnal Blood Pressure in Hypertension: Antihypertensive Strategy for Nocturnal Blood Pressure | Clinical and Experimental Hypertension | 2004 | 121 |
| 15 | Mechanisms of Insulin Action on Sympathetic Nerve Activity | Clinical and Experimental Hypertension | 1995 | 118 |
| 16 | Protective Effects of Candesartan Cilexetil (TCV-116) Against Stroke, Kidney Dysfunction and Cardiac Hypertrophy in Stroke-Prone Spontaneously Hypertensive Rats | Clinical and Experimental Hypertension | 1997 | 112 |
| 17 | The Renin — Angiotensin — Aldosterone System in Pre-Eclampsia | Clinical and Experimental Hypertension | 1997 | 107 |
| 18 | Nimodipine and Its Use in Cerebrovascular Disease: Evidence from Recent Preclinical and Controlled Clinical Studies | Clinical and Experimental Hypertension | 2008 | 107 |
| 19 | The Cellular Mechanism of Action of Cardiotonic Steroids: A New Hypothesis | Clinical and Experimental Hypertension | 1998 | 105 |
| 20 | Simultaneous Measurement of Marinobufagenin, Ouabain, and Hypertension-associated Protein In Various Disease States | Clinical and Experimental Hypertension | 1998 | 104 |
| 21 | Observations on the Nature, Biosynthesis, Secretion and Significance of Endogenous Ouabain | Clinical and Experimental Hypertension | 1998 | 101 |
| 22 | Endogenous Marinobufagenin-Like Factor In Acute Plasma Volume Expansion | Clinical and Experimental Hypertension | 1998 | 95 |
| 23 | Cardiovascular Tissues Contain Independent Circadian Clocks | Clinical and Experimental Hypertension | 2005 | 94 |
| 24 | Cardiovascular and Endocrine Effects of Acupuncture in Hypertensive Patients | Clinical and Experimental Hypertension | 1997 | 91 |
| 25 | The Comparative Effects of Valsartan and Amlodipine on vWf Levels and N/L Ratio in Patients with Newly Diagnosed Hypertension | Clinical and Experimental Hypertension | 2013 | 91 |
| 26 | Anti-Hypertensive Effect of γ-Aminobutyric Acid (GABA)-RichChlorellaon High-Normal Blood Pressure and Borderline Hypertension in Placebo-Controlled Double Blind Study | Clinical and Experimental Hypertension | 2009 | 88 |
| 27 | Compliance with Antihypertensive Therapy | Clinical and Experimental Hypertension | 1999 | 87 |
| 28 | Functional Anatomy of Sympathetic Premotor Cell Groups in the Medulla | Clinical and Experimental Hypertension | 1995 | 85 |
| 29 | Diabetes and Hypertension: Pathogenesis, Prevention and Treatment | Clinical and Experimental Hypertension | 2004 | 84 |
| 30 | Plasma Apelin and ADMA Levels in Patients with Essential Hypertension | Clinical and Experimental Hypertension | 2010 | 82 |
| 31 | PHARMACOLOGICAL EVIDENCE OF HYPOTENSIVE ACTIVITY OFMARRUBIUM VULGAREANDFOENICULUM VULGAREIN SPONTANEOUSLY HYPERTENSIVE RAT | Clinical and Experimental Hypertension | 2001 | 81 |
| 32 | Angiotensin as Neuromodulator/Neurotransmitter in Central Control of Body Fluid and Electrolyte Homeostasis | Clinical and Experimental Hypertension | 1995 | 79 |
| 33 | The Evidence for a Pathophysiologic Significance of the Sympathetic Overactivity in Hypertension | Clinical and Experimental Hypertension | 1996 | 79 |
| 34 | OBESITY AND AUTONOMIC FUNCTION IN ADOLESCENCE | Clinical and Experimental Hypertension | 2001 | 79 |
| 35 | Fractal and Complexity Measures of Heart Rate Variability | Clinical and Experimental Hypertension | 2005 | 79 |
| 36 | Direct Vasoactive Effects of the Chromogranin A (CHGA) Peptide Catestatin in HumansIn Vivo | Clinical and Experimental Hypertension | 2010 | 79 |
| 37 | Matrix Metalloproteinases: Discrete Elevations in Essential Hypertension and Hypertensive End-Stage Renal Disease | Clinical and Experimental Hypertension | 2009 | 78 |
| 38 | The Beneficial Effect of Regular Endurance Exercise Training on Blood Pressure and Quality of Life in Patients with Hypertension | Clinical and Experimental Hypertension | 2004 | 77 |
| 39 | Vascular Oxidative Stress Precedes High Blood Pressure in Spontaneously Hypertensive Rats | Clinical and Experimental Hypertension | 2005 | 76 |
| 40 | Integration in the Ventral Medulla and Coordination of Sympathetic, Pain and Arousal Functions | Clinical and Experimental Hypertension | 1995 | 75 |
| 41 | The Role of Kinins and Atrial Natriuretic Peptide on the Renal Effects of Neutral Endopeptidase Inhibitor in Rats | Clinical and Experimental Hypertension | 1994 | 74 |
| 42 | Plasminogen Activator Inhibitor-1 and the Circadian Clock in Metabolic Disorders | Clinical and Experimental Hypertension | 2009 | 74 |
| 43 | Effect of γ-Tocotreenol on Blood Pressure, Lipid Peroxtoation and Total Antioxtoant Status in Spontaneously Hypertensive Rats (SHR) | Clinical and Experimental Hypertension | 1999 | 73 |
| 44 | Homocyst(E)Ine and Heart Disease: Pathophysiology of Extracellular Matrix | Clinical and Experimental Hypertension | 1999 | 72 |
| 45 | Different Effect of Psyllium and Guar Dietary Supplementation on Blood Pressure Control in Hypertensive Overweight Patients: A Six-Month, Randomized Clinical Trial | Clinical and Experimental Hypertension | 2007 | 72 |
| 46 | Dose-Dependent Reduction of Myocardial Infarct Mass in Rabbits by the NHE-1 Inhibitor Cariporide (HOE 642) | Clinical and Experimental Hypertension | 1998 | 70 |
| 47 | Use of C-Fos Functional Mapping to Identify the Central Baroreceptor Reflex Pathway: Advantages and Limitations | Clinical and Experimental Hypertension | 1995 | 69 |
| 48 | Arterial Hypertension and Brain Damage—Evidence from Animal Models (Review) | Clinical and Experimental Hypertension | 2003 | 69 |
| 49 | Circulating miR-21 and eNOS in subclinical atherosclerosis in patients with hypertension | Clinical and Experimental Hypertension | 2015 | 69 |
| 50 | Decreased Superoxide Dismutase Activity and Increased Superoxide Anion Production in Cardiac Hypertrophy of Spontaneously Hypertensive Rats | Clinical and Experimental Hypertension | 1995 | 67 |
